Farmacéuticos Comunitarios. 2018 Jun 30; 10(2):15-20 DOI: 10.5672/FC.2173-9218.(2018/Vol10).002.03

Collaboration of a health and social services center and community pharmacies in reviewing medications and processing personalized dosing systems

Mud Castelló F1, Mud Castelló S2, Rodríguez Moncho MJ2, Signes Mut A1, Muñoz Ballester P3
1. Farmacéutico comunitario. Farmacia Fernando Mud (Ondara). 2. Farmacéutica comunitaria. Farmacia M. Dolores Castelló (Ondara). 3. Médico residencia Nuestra Señora de la Soledad (Ondara).
Mud F, Mud S, Rodríguez MJ, Signes A, Muñoz P. Colaboración de un centro sociosanitario y dos farmacias comunitarias en la revisión de la medicación y elaboración de sistemas personalizados de dosificación. Farmacéuticos Comunitarios. 2018 Jun 30; 10(2):15-20 DOI: 10.5672/FC.2173-9218.(2018/Vol10).002.03
Abstract : 

Introduction: Institutionalized patients have, by their characteristics, more possibilities of presenting security problems with medication. The community pharmacy can offer different services, such as medication review. For this, we have the STOPP criteria, which detect potentially inappropriate prescriptions (PPI) and the START that detect potentially omitted prescriptions (PPO). In addition to the medication review, the community pharmacist has personalized dispensation systems (SPD).

Objective: Facilitate adherence to the prescribed medications in a social-health center with the help of the SPD carried out by community pharmacists.

Methodology: Prospective study carried out in two community pharmacies and in a social health center (25 residents) of Ondara for eight months (January-August 2017). It involved a doctor, a nurse and four community pharmacists.

Results: 31 patients were included, which generated 62 reviews of the medication. The average age was 83 years. 16 PPI were detected and the doctor accepted 50% of them. The most detected STOPP criterion was B9: loop diuretics for the treatment of hypertension with urinary incontinence.

25 PPO criteria were detected and the doctor accepted 28% of them. The most detected START criterion was E4: Antiresorptive or bone anabolic agents in patients with osteopororosis.

Conclusions: The administration of medication in the social-health center has been facilitated since the MDSs were carried out by the community pharmacists. With the review of the medication the community pharmacist helped the doctor to optimize the pharmacotherapy of admitted patients.

Article download link: